Treatment Information

The clinical HIFU unit at the Churchill Hospital opened in July 2002. Clinical trials investigating the use of the Chongqing Haifu System for the treatment of liver and kidney tumours began late in 2002. Data arising from the treatment of the first 30 patients in these trials was submitted to the regulatory authorities and resulted in the award of a CE mark in July 2005. These clinical trials are ongoing.

Since the award of the CE mark for the treatment of liver and kidney tumours we are also able to consider patients for treatment off trial for these applications. However the treatment is not yet available on the National Health Service.

Other types of tumour have also been treated in China including those of the pancreas, bone, soft tissues and breast. Although these applications are not yet covered by a CE mark, treatment of these conditions could be considered on an individual basis under certain circumstances.

Visit the Patient Website or click for further options in the left hand menu..